Patients Helping Patients
PF Warriors is excited to invite you to a special Zoom clinical trial presentation. Join us to learn about BEACON-IPF, a global 2b clinical trial to evaluate the investigational drug bexotegrast for the treatment of idiopathic pulmonary fibrosis (IPF).
Whether you are new to clinical trials or have prior experience, this presentation will provide valuable insights into the future treatment options for pulmonary fibrosis (PF). Join Dr. Gregory Cosgrove, MD, FCCP as he discusses how you can contribute to advancing treatment options for PF.
Topics to be discussed:
Learn more about Gregory Cosgrove, MD, FCCP.
Become a PF Warriors Member!
Membership is always FREE! By becoming a member of the PF Warriors community, you will gain exclusive access to incredible resources designed to support and empower you on your journey with pulmonary fibrosis.
As a member, you will:
What is Pulmonary Fibrosis?
Pulmonary fibrosis is a progressive lung disorder characterized by the formation of scar tissue in the lungs. This scarring leads to breathing difficulties, diminished lung function, and lower oxygen levels in the bloodstream..